Neuroimmunology Drug

Contacte al anunciante
(617) 455-4188
Contacte al anunciante

We present the Neuroimmunology Drug Development Summit, the industry's definitive and unrivalled forum focused on pushing the frontiers of targeting neuroinflammation for CNS Indications.


As diverse programs are advancing towards the clinic, there is a dire need to tackle the many translational challenges neuro-immunologists are facing to develop clinically effective neuroimmunology targeted therapeutics.


Building on the success of last year's meeting, this year's program will uncover how leading companies in this emerging field are discovering immune-modulating targets and deploying immuno-neurology across clinical case studies. As we gather the best minds in this infant field we will put a spotlight on the latest key learnings across microglia, astrocytes, STING, TREM2 and more to help pave the way to translating key technological and mechanistic insights towards the clinic.


Join this intimate, industry led forum to not only learn from those pioneering the field, but to network and build meaningful partnerships with 80+ neuroimmunology drug development experts.


Tickets: https://go.evvnt.com/729873-2?pid=6842


Date and Time: On Tuesday April 27, 2021 at 9:00 am (ends Thursday April 29, 2021 at 5:00 pm)


Venue details: Online


Prices:
Conference + 2 Workshops: USD 2997.00,
Conference + 1 Workshop: USD 2498.00,
Conference Only: USD 2299.00


Speakers: Andrea Crotti, Principal Scientist - Early Target Discovery, Takeda, Brad Friedman, Senior Scientist, Department of OMNI Bioinformatics, Genentech, Carlos Pedraza, Associate Director Neuroimmunology and MS Therapeutics, Sanofi, Charlotte Callaghan, Chief Scientific Officer and Patient Insight Manager, Ulysses Neuroscience, Christian Mirescu, Principal scientist, Neuroimmunology, Merck, Courtney Easley-Neal, Senior Scientist, In Vivo Biology and Imaging, EISAI, Graham T. Dempsey, Chief Scientific Officer, Q-State Biosciences, Juan Pablo De Rivero Vaccari, Research Assistant Professor, University of Miami Miller School of Medicine, Kristina Holmberg, Associate Director, Translational and Clinical Biomarkers, EMD Serono, M. Kerry O'Banion MD, Professor and Vice Chair, Department of Neuroscience, University of Rochester, School of Medicine and Dentistry, and more.

We present the Neuroimmunology Drug Development Summit, the industry's definitive and unrivalled forum focused on pushing the frontiers of targeting neuroinflammation for CNS Indications.


As diverse programs are advancing towards the clinic, there is a dire need to tackle the many translational challenges neuro-immunologists are facing to develop clinically effective neuroimmunology targeted therapeutics.


Building on the success of last year's meeting, this year's program will uncover how leading companies in this emerging field are discovering immune-modulating targets and deploying immuno-neurology across clinical case studies. As we gather the best minds in this infant field we will put a spotlight on the latest key learnings across microglia, astrocytes, STING, TREM2 and more to help pave the way to translating key technological and mechanistic insights towards the clinic.


Join this intimate, industry led forum to not only learn from those pioneering the field, but to network and build meaningful partnerships with 80+ neuroimmunology drug development experts.


Tickets: https://go.evvnt.com/729873-2?pid=6842


Date and Time: On Tuesday April 27, 2021 at 9:00 am (ends Thursday April 29, 2021 at 5:00 pm)


Venue details: Online


Prices:
Conference + 2 Workshops: USD 2997.00,
Conference + 1 Workshop: USD 2498.00,
Conference Only: USD 2299.00


Speakers: Andrea Crotti, Principal Scientist - Early Target Discovery, Takeda, Brad Friedman, Senior Scientist, Department of OMNI Bioinformatics, Genentech, Carlos Pedraza, Associate Director Neuroimmunology and MS Therapeutics, Sanofi, Charlotte Callaghan, Chief Scientific Officer and Patient Insight Manager, Ulysses Neuroscience, Christian Mirescu, Principal scientist, Neuroimmunology, Merck, Courtney Easley-Neal, Senior Scientist, In Vivo Biology and Imaging, EISAI, Graham T. Dempsey, Chief Scientific Officer, Q-State Biosciences, Juan Pablo De Rivero Vaccari, Research Assistant Professor, University of Miami Miller School of Medicine, Kristina Holmberg, Associate Director, Translational and Clinical Biomarkers, EMD Serono, M. Kerry O'Banion MD, Professor and Vice Chair, Department of Neuroscience, University of Rochester, School of Medicine and Dentistry, and more.

Contacte al anunciante
Contacte al anunciante
Ingrese su email: (Requerido) El email no es valido.
Mensaje para el anunciante: (Requerido) El texto no es valido.